Trial Profile
A Phase IIa Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of JNJ-38518168 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy With Synovial Biopsy Substudy.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Toreforant (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Janssen-Cilag
- 04 Jun 2013 Status changed from active, no longer recruiting to discontinued.
- 24 Mar 2012 Planned number of patients changed from 90 to 95 as reported by European Clinical Trials Database.
- 08 Jun 2011 Status changed from completed to active, no longer recruiting as reported by UKCRN record.